Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Genomics & Proteomics
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Cancer Genomics & Proteomics

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Research Article
Open Access

Loss of Both USP10 and p14ARF Protein Expression Is an Independent Prognostic Biomarker for Poor Prognosis in Patients With Epithelial Ovarian Cancer

GWAN HEE HAN, DOO BYUNG CHAY, JOO MI YI, HANBYOUL CHO, JOON-YONG CHUNG and JAE-HOON KIM
Cancer Genomics & Proteomics November 2019, 16 (6) 553-562; DOI: https://doi.org/10.21873/cgp.20157
GWAN HEE HAN
1Department of Obstetrics and Gynecology, Yonsei University College of Medicine, Seoul, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOO BYUNG CHAY
1Department of Obstetrics and Gynecology, Yonsei University College of Medicine, Seoul, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JOO MI YI
2Department of Microbiology and Immunology, Inje University College of Medicine, Busan, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HANBYOUL CHO
1Department of Obstetrics and Gynecology, Yonsei University College of Medicine, Seoul, Republic of Korea
3Experimental Pathology Laboratory, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: hanbyoul@yuhs.ac
JOON-YONG CHUNG
3Experimental Pathology Laboratory, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JAE-HOON KIM
1Department of Obstetrics and Gynecology, Yonsei University College of Medicine, Seoul, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 16 no. 6 553-562
DOI 
https://doi.org/10.21873/cgp.20157
PubMed 
31659108

Published By 
International Institute of Anticancer Research
Print ISSN 
1109-6535
Online ISSN 
1790-6245
History 
  • Received July 19, 2019
  • Revision received July 28, 2019
  • Accepted August 1, 2019
  • Published online October 28, 2019.

Copyright & Usage 
Copyright© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved

Author Information

  1. GWAN HEE HAN1,
  2. DOO BYUNG CHAY1,
  3. JOO MI YI2,
  4. HANBYOUL CHO1,3⇑,
  5. JOON-YONG CHUNG3 and
  6. JAE-HOON KIM1
  1. 1Department of Obstetrics and Gynecology, Yonsei University College of Medicine, Seoul, Republic of Korea
  2. 2Department of Microbiology and Immunology, Inje University College of Medicine, Busan, Republic of Korea
  3. 3Experimental Pathology Laboratory, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, U.S.A.
  1. Correspondence to: Hanbyoul Cho, MD, Ph.D., Associate Professor, Department of Obstetrics and Gynecology, Gangnam Severance Hospital, Yonsei University College of Medicine, #222 Research Center for Future Medicine, Enoju-Ro 63-gil, Gangnam-Gu, Seoul 06229, Republic of Korea. Tel: +82 220193430, Fax: +82 234628209, e-mail: hanbyoul{at}yuhs.ac
View Full Text

Cited By...

  • 13 Citations
  • Google Scholar
PreviousNext
Back to top

In this issue

Cancer Genomics - Proteomics: 16 (6)
Cancer Genomics & Proteomics
Vol. 16, Issue 6
November-December 2019
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cancer Genomics & Proteomics.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Loss of Both USP10 and p14ARF Protein Expression Is an Independent Prognostic Biomarker for Poor Prognosis in Patients With Epithelial Ovarian Cancer
(Your Name) has sent you a message from Cancer Genomics & Proteomics
(Your Name) thought you would like to see the Cancer Genomics & Proteomics web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
4 + 3 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Loss of Both USP10 and p14ARF Protein Expression Is an Independent Prognostic Biomarker for Poor Prognosis in Patients With Epithelial Ovarian Cancer
GWAN HEE HAN, DOO BYUNG CHAY, JOO MI YI, HANBYOUL CHO, JOON-YONG CHUNG, JAE-HOON KIM
Cancer Genomics & Proteomics Nov 2019, 16 (6) 553-562; DOI: 10.21873/cgp.20157

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Loss of Both USP10 and p14ARF Protein Expression Is an Independent Prognostic Biomarker for Poor Prognosis in Patients With Epithelial Ovarian Cancer
GWAN HEE HAN, DOO BYUNG CHAY, JOO MI YI, HANBYOUL CHO, JOON-YONG CHUNG, JAE-HOON KIM
Cancer Genomics & Proteomics Nov 2019, 16 (6) 553-562; DOI: 10.21873/cgp.20157
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

Similar Articles

Keywords

  • Epithelial ovarian cancer
  • tumor marker
  • USP10
  • p14ARF
Cancer & Genome Proteomics

© 2023 Cancer Genomics & Proteomics

Powered by HighWire